{"a":[{"_":"What’s Next in Immuno-Oncology - A Visionary Conversation with Dr Ira Mellman","$":{"href":"/partner-content/whats-next-immuno-oncology-visionary-conversation-dr-ira-mellman","hreflang":"en"}}]}

Summary

FiercePharma features a podcast conversation between Dr. Ira Mellman from PICI and Dr. Axel Hoos, former CEO of Scorpion Therapeutics, discussing immuno-oncology trends at the 2026 Immuno-Oncology 360° conference.